The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 301–400 of 849
Błażejewski, A. J., Thiemann, S., Schenk, A., Pils, M. C., Gálvez, E. J. C., Roy, U., Heise, U., de Zoete, M. R., Flavell, R. A., & Strowig, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.058 · Cited by 75
“The situation has been similarly controversial in the case of in-flammasomes and specifically caspase-1 activation (Allen et al., 2010; Bauer et al., 2010; Dupaul-Chicoine et al., 2010; Siegmund et al., 2001; Zaki et al., 2010a) (Table S1).”
InfluentialRaut, P. K., Kim, S., Choi, D. Y., Jeong, G., & Park, P. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.006 · Cited by 68
Promising targets based on pattern recognition receptors for cancer immunotherapy
Bai, L., Li, W., Zheng, W., Xu, D., Chen, N., & Cui, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105017 · Cited by 71
Inflammasome as a promising therapeutic target for cancer
Lee, C., Do, H. T. T., Her, J., Kim, Y., Seo, D., & Rhee, I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116593 · Cited by 69
MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI
Jiang, R., Chen, X., Ge, S., Wang, Q., Liu, Y., Chen, H., Xu, J., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.610545 · Cited by 72
“However, recent studies demonstrated that the regulation and suppression of NLRC4 is not always consistent between cancer models or even within the same CRC model (45, 46).”
ResultThe Dual Role of Nod-Like Receptors in Mucosal Innate Immunity and Chronic Intestinal Inflammation
Corridoni, D., Arseneau, K. O., Cifone, M. G., & Cominelli, F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00317 · Cited by 81
“NLRP6 NLRP6 is high expressed in the duodenum, ileum, and colon, primarily within the hematopoietic compartment by macrophages, dendritic cells, lymphocytes, and granulocytes (74, 76, 77).”
BackgroundHaneklaus, M., O’Neil, J. D., Clark, A. R., Masters, S. L., & O’Neill, L. A. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772947 · Cited by 65
“Conflicting results have been reported about the role of inflammasomes in DSS colitis, with some reports finding that mice deficient in inflammasome components are protected (69, 70), whereas others report the opposite (71, 72).”
BackgroundTenthorey, J. L., Chavez, R. A., Thompson, T. W., Deets, K. A., Vance, R. E., & Rauch, I. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191736 · Cited by 67
“, 2010), although others found that caspase-1 but not NLRC4 was protective in the samemodel (Allen et al., 2010).”
BackgroundInterleukin-1 (IL-1) and the inflammasome in cancer
Prêtre, V., Papadopoulos, D., Regard, J. B., Pelletier, M. R., & Woo, J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155850 · Cited by 70
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
Colombo, M., Mirandola, L., Chiriva‐Internati, M., Basile, A., Locati, M., Lesma, E. A., Chiaramonte, R., & Platonova, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01823 · Cited by 71
“A protective role for IL-1β is reported in models of colon cancer associated to colitis, possibly due to the concomitant production of IL-18, relevant for intestine healing (183), or in a model of epithelial skin carcinogenesis, where the inflammasome adapter ASC may play a protective role in keratinocytes.”
BackgroundBile acid analogues are activators of pyrin inflammasome
Alimov, I., Menon, S., Cochran, N., Maher, R., Wang, Q., Alford, J., Concannon, J. B., Yang, Z., Harrington, E., Llamas, L., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005103 · Cited by 64
“For example, mice deficient in the inflammasome sensors NLRP3, NLRP6, and Pyrin all display impaired immune responses, exacerbation of chemically induced colitis, and dysbiosis of the gut microbiota (4-6).”
BackgroundNOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers
Zhou, Y., Yu, S., & Zhang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914511 · Cited by 79
From Inflammation to Prostate Cancer: The Role of Inflammasomes
Karan, D., & Dubey, S. (2016) · Advances in Urology · doi:10.1155/2016/3140372 · Cited by 69
“However, studies in chemically induced colitis model showed that the mice lacking NLRP3 are highly susceptible to tumor formation with severe inflammation [56].”
BackgroundYin, X., Zhang, Q., Chen, Z., Wang, H., Li, X., Wang, H., Li, H., Kang, C., Chu, S., Li, K., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4480 · Cited by 69
“A previous study reported that the assembly and activation of the NLRP3 inflammasome complex, constructed of NLRP3, ASC, caspase-1 and pro-IL-1 β proteins, functions as a negative regulator in the carcinogenesis of colitis-associated cancer (27).”
Canonical and noncanonical inflammasomes in intestinal epithelial cells
Winsor, N. J., Krustev, C., Bruce, J. K., Philpott, D. J., & Girardin, S. E. (2019) · Cellular Microbiology · doi:10.1111/cmi.13079 · Cited by 74
“, 2010), bone marrow chimera experiments have demonstrated that the function of NLRP3 in these models is limited to the haematopoietic compartment (Allen et al., 2010; Bauer et al., 2010).”
BackgroundInfluentialDivergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation
McEntee, C. P., Finlay, C. M., & Lavelle, E. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01266 · Cited by 70
“Furthermore, more recent studies have demonstrated that Pycard mice also display enhanced tumor burden and metastasis compared to wild-types in a murine CRC model which involves exposure to AOM prior to DSS administration (228).”
BackgroundLow NLRP3 expression predicts a better prognosis of colorectal cancer
Shi, F., Wei, B., Lan, T., Xiao, Y., Quan, X., Chen, J., Zhao, C., & Gao, J. (2021) · Bioscience Reports · doi:10.1042/bsr20210280 · Cited by 65
Licandro, G., Ling Khor, H., Beretta, O., Lai, J., Derks, H., Laudisi, F., Conforti‐Andreoni, C., Liang Qian, H., Gee Teng, G., Ricciardi‐Castagnoli, P., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242918 · Cited by 62
The contrasting roles of inflammasomes in cancer.
He, Q., Fu, Y., Tian, D., & Yan, W. (2018) · Europe PMC (PubMed Central) · Cited by 73
Savic, S., Dickie, L. J., Wittmann, M., & McDermott, M. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.07.009 · Cited by 70
Skeldon, A., & Saleh, M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00015 · Cited by 59
“In addition, upon tissue damage, Nlrp3 inflammasomedependent production of IL-18 was shown to be required for tissue repair and protection from colitis and colitis-associated colorectal cancer (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Saleh and Trinchieri, 2011; Zaki et al., 2010).”
BackgroundGao, H., Cao, M., Yao, Y., Hu, W., Sun, H., Zhang, Y., Zeng, C., Tang, J., Luan, S., & Chen, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750841 · Cited by 65
Dendritic cell–epithelial cell crosstalk in the gut
Rescigno, M. (2014) · Immunological Reviews · doi:10.1111/imr.12181 · Cited by 64
“IL-1b has been implicated in the pathology of Crohn’s disease (37); however, contrary to what is expected, and still controversial (38,39), mice deficient for Nlpr3 or caspase 1 are more susceptible to DSS-induced colitis and colitis-associated intestinal tumorigenesis (40,41).”
ResultNod-like receptors in intestinal homeostasis, inflammation, and cancer
Werts, C., Rubino, S. J., Ling, A., Girardin, S. E., & Philpott, D. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411183 · Cited by 67
“As detailed above, several independent studies suggest a protective role of the NLRP3 inflammasome [13, 26–28] in the DSS-induced colitis model.”
BackgroundInfluentialNLRP3 inflammasome in colitis and colitis-associated colorectal cancer
Perera, A. P., Sajnani, K., Dickinson, J. L., Eri, R. D., & Körner, H. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9783-2 · Cited by 64
PRR Function of Innate Immune Receptors in Recognition of Bacteria or Bacterial Ligands
Gulati, A., Kaur, D., Prasad, G. V. R. K., & Mukhopadhaya, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3065-0_18 · Cited by 65
NLRP3 inflammasomes that induce antitumor immunity
Zhivaki, D., & Kagan, J. C. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.05.001 · Cited by 63
Zhang, Y., Tao, M., Chen, C., Zhao, X., Feng, Q., Chen, G., & Fu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.783254 · Cited by 82
Aguilera, M., Darby, T. M., & Melgar, S. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.04.003 · Cited by 67
Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
Yu, X., Zhao, Q., Zhang, X., Zhang, H., Liu, Y., Wu, X., Li, M., Li, X., Zhang, J., Ruan, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18619 · Cited by 63
“Studies have reported that Nlrp3-/- mice are more susceptible to colitis and colon tumorgenesis [39, 51].”
BackgroundThe microbiome and cytosolic innate immune receptors
Liwinski, T., Zheng, D., & Elinav, E. (2020) · Immunological Reviews · doi:10.1111/imr.12901 · Cited by 65
Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy
Higashimori, A., Watanabe, T., Nadatani, Y., Takeda, S., Otani, K., Tanigawa, T., Yamagami, H., Shiba, M., Tominaga, K., Fujiwara, Y., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.89 · Cited by 61
“In addition, mice lacking caspase-1 and ASC were found to be highly susceptible to dextran sulfate sodium-induced colitis compared with wildtype animals.(20,33,35) The phenotype in caspase-1 / mice was rescued by administration of exogenous IL-18,(20,35) suggesting IL-18 significantly contributes to the inflammasome’s…”
BackgroundWang, Y., Wang, H., Qian, C., Tang, J., Zhou, W., Liu, X., You, Q., & Hu, R. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.015 · Cited by 62
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
Salaro, E., Rambaldi, A., Falzoni, S., Amoroso, F. S., Franceschini, A., Sarti, A. C., Bonora, M., Cavazzini, F., Rigolin, G. M., Ciccone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep26280 · Cited by 56
Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs
Zhang, S., Liang, Y., Yao, J., Li, D., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.833588 · Cited by 68
“In different mouse models (DSS, Oxazolone, and TNBS models) NLRP3 has been shown to protect epithelial integrity, regulate intestinal homeostasis, and attenuate experimental colitis (Allen et al., 2010; Zaki et al., 2010; Hirota et al., 2011).”
BackgroundDisulfiram with Cu2+ alleviates dextran sulfate sodium-induced ulcerative colitis in mice
Zhou, W., Zhang, H., Huang, L., Sun, C., Yue, Y., Cao, X., Jia, H.-L., Wang, C., & Gao, Y. (2023) · Theranostics · doi:10.7150/thno.81571 · Cited by 65
“Multiple studies have shown that NLRP3 inflammasomes are mainly produced by macrophages and are closely associated with UC [22, 53, 54].”
BackgroundChilton, P. M., Eaves, C. A., & Mitchell, T. C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00154 · Cited by 63
Boersma, B., Jiskoot, W., Lowe, P. R., & Bourquin, C. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.09.004 · Cited by 62
Inflammasomes in Cancer Progression and Anti-Tumor Immunity
Lillo, S., & Saleh, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839041 · Cited by 62
“Concordantly, loss of Nlrp3, Asc or caspase-1 led to severe colitis but also to colitis-associated CRC (CAC) (Allen et al., 2010).”
BackgroundInflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Westbom, C., Thompson, J. K., Leggett, A., MacPherson, M., Beuschel, S., Pass, H., Vacek, P., & Shukla, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145404 · Cited by 56
“For example, 2 groups independently reported that the absence of NLRP3 and caspase-1 attenuated chemical-induced colitis in mice [9, 10], whereas other groups have reported that different inflammasome knockout (KO) mice are more sensitive to chemical-induced colitis and tumorigenesis [11, 12].”
BackgroundLoss of TLR2 Worsens Spontaneous Colitis in MDR1A Deficiency through Commensally Induced Pyroptosis
Ey, B., Eyking, A., Klepak, M., Salzman, N. H., Göthert, J. R., Rünzi, M., Schmid, K. W., Gerken, G., Podolsky, D. K., & Cario, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201592 · Cited by 56
Role of the nucleotide‐binding domain‐like receptor protein 3 inflammasome in acute kidney injury
Cao, Y., Fei, D., Chen, M., Sun, M., Xu, J., Kang, K., Jiang, L., & Zhao, M. (2015) · FEBS Journal · doi:10.1111/febs.13379 · Cited by 58
Kim, Y.-R., Hwang, J., Koh, H.-J., Jang, K., Lee, J.-D., Choi, J. H., & Yang, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.035 · Cited by 55
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
Karan, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03028 · Cited by 58
“Utilizing azoxymethane (AOM)/dextran sodium sulfate (DSS) model, it was shown that NLRC4 knockout mice developed increased tumor volume (26).”
MethodResultInflammasome in Intestinal Inflammation and Cancer
Nunes, T., & de Souza, H. S. P. (2013) · Mediators of Inflammation · doi:10.1155/2013/654963 · Cited by 56
Watanabe, D., Guo, Y., & Kamada, N. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013452 · Cited by 61
Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., McDaniel, D. K., Coutermarsh‐Ott, S. L., Simmons, A., Kable, K. H., Heid, B., & Allen, I. C. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00234.2014 · Cited by 57
“) using a dissecting microscope ( 10 magnification), and the size was determined by taking multiple measurements across the maximum surface of each macroscopic polyp (4, 5).”
BackgroundMethodInfluentialSelf-citationLiu, W., Guo, W., Zhu, Y., Peng, S., Zheng, W., Zhang, C., Shao, F., Zhu, Y., Hang, N., Kong, L., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700796 · Cited by 55
Tumor-intrinsic determinants of immunogenic cell death modalities
Workenhe, S. T., Pol, J. G., & Kroemer, G. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1893466 · Cited by 53
The role of pyroptosis in modulating the tumor immune microenvironment
Wu, J., Wang, L., & Xu, J. (2022) · Biomarker Research · doi:10.1186/s40364-022-00391-3 · Cited by 55
“A protective effect of IL-1β in mouse models of chemically induced colon carcinoma was observed [102], whereas recombinant IL-18 promoted T-cell acute leukemia growth in vitro [103].”
BackgroundInflammasomes: Caspase-1-Activating Platforms with Critical Roles in Host Defense
Vande Walle, L., & Lamkanfi, M. (2011) · Frontiers in Microbiology. · doi:10.3389/fmicb.2011.00003 · Cited by 50
“…caspases, interleukin (IL)-1β-converting enzyme and later renamed caspase-1, has been linked to inflammatory bowel diseases (Villani et al., 2009; Allen et al., 2010; Dupaul-Chicoine et al., 2010; Zaki et al., 2010a,b), gouty arthritis (Martinon et al., 2006), type II diabetes (Larsen et al.,…”
BackgroundSfakianoudis, K., Maziotis, E., Karantzali, E., Kokkini, G., Grigoriadis, S., Pantou, A., Giannelou, P., Petroutsou, K., Markomichali, C., Fakiridou, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158353 · Cited by 53
Microbial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 51
Hu, B., Elinav, E., & Flavell, R. A. (2011) · Cell Cycle · doi:10.4161/cc.10.12.16008 · Cited by 53
Yang, Z., Cao, J., Yu, C., Yang, Q., Zhang, Y., & Han, L. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2015.07.006 · Cited by 53
Isolation, Culture, and Functional Evaluation of Bone Marrow-Derived Macrophages
Davis, B. K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-481-4_3 · Cited by 50
NLRP3 inflammasome-induced pyroptosis in digestive system tumors
Wen, J., Xuan, B., Liu, Y., Wang, L., He, L., Meng, X., Zhou, T., & Wang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074606 · Cited by 53
“Thus, the NLRP3 inflammasome is considered instrumental in resistance to colitis-associated tumorigenesis (128, 129).”
BackgroundErasha, A. M., El-Gendy, H. F., Aly, A. S., Fernández‐Ortiz, M., & Sayed, R. K. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062716 · Cited by 54
“ABHD5 plays a crucial role in lipid metabolism, and its absence has been found to enhance macrophage reprogramming and inflammasome activation, further highlighting the connection between metabolic alterations in the TME and inflammasome activation [251].”
Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome
Dai, G., Jiang, Z., Sun, B., Liu, C., Meng, Q., Ding, K., Jing, W., & Ju, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00721 · Cited by 54
“Altogether, our findings demonstrate that CAPE prevents CAC by post-transcriptionally inhibiting NLRP3 inflammasome.”
BackgroundInfluentialZhang, Z., Shen, P. F., Lu, X., Li, Y., Liu, J., Liu, B., Fu, Y., Cao, Y., & Zhang, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00558 · Cited by 52
“showed that NLRP3-deficient mice are more susceptible to develop colitis (34).”
BackgroundInflammatory cell death in intestinal pathologies
Sharma, D., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12602 · Cited by 51
“Nlrp3−/− DSS colitis Susceptible Similar TUNEL (+) cells, reduced cl- casp- 1 (72, 73, 74)”
BackgroundJin, H., Ko, G. H., & Kim, H. J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4552 · Cited by 51
“The activation of the inflammasome is beneficial in colitis-associated colorectal cancer, mostly due to the positive epithelial effects of the IL-18 signaling pathway, the control of cellular proliferation, the maturation and main‐ tenance of a healthy gut microbiota and cell death (44,45).”
Therapeutic implications of inflammasome in inflammatory bowel disease
Khatri, V., & Kalyanasundaram, R. (2021) · The FASEB Journal · doi:10.1096/fj.202002622r · Cited by 51
Obesity, obesities and gastrointestinal cancers
Zou, Y., & Pitchumoni, C. S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101592 · Cited by 56
Regulation of inflammation by DAPK
Lai, M., & Chen, R. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0933-4 · Cited by 50
Microbiota and innate immunity in intestinal inflammation and neoplasia
Cario, E. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a670e · Cited by 46
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
Vong, C. T., Tseng, H. H. L., Yao, P., Yu, H., Wang, S., Zhong, Z., & Wang, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.018 · Cited by 51
Scarpitta, A., Hacker, U. T., Büning, H., Boyer, O., & Adriouch, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.731598 · Cited by 51
Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
Bi, Q., Wu, J., Qiu, X., Zhang, J., Sun, Z., & Wang, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/3128933 · Cited by 52
“Similarly, the lack of IL-1R helped to protect mice from MAC-induced fi brosarcoma, and the same result could be observed in Nlrp3 -/- or Caspl -/- mice; this may be related to NLRP3 inhibiting the function of NK cells [127].”
The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target
Vafaei, S., Taheri, H., Hajimomeni, Y., Yaseri, A. F., & Zadeh, F. A. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02861-4 · Cited by 47
“NLRP3 was found to be required for tumor suppression in hematopoietic cells in bone marrow chimera studies [31, 32].”
BackgroundThe inflammasome NLRP3 plays a protective role against a viral immunopathological lesion
Giménez, F., Bhela, S., Dogra, P., Harvey, M. L., Varanasi, S. K., Jaggi, U., & Rouse, B. T. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0715-321r · Cited by 47
Hajek, E., Krebs, F. K., Bent, R., Haas, K., Bast, A., Steinmetz, I., Tuettenberg, A., Grabbe, S., & Bros, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25511 · Cited by 48
“In chemically induced colon cancer models mice with a defective inflammasome showed stronger tumor induction and progression than WT mice suggesting a protective role of the inflammasome [31].”
BackgroundThe Multifaceted Role of the Inflammasome in Inflammatory Bowel Diseases
Lissner, D., & Siegmund, B. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.139 · Cited by 51
“Several recent studies provide explicit data that Nlrp3 -/mice are more prone to develop colitis[14,66,67].”
BackgroundCanonical and non-canonical functions of NLRP3
Accogli, T., Hibos, C., & Végran, F. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.001 · Cited by 51
Bacterial lipopolysaccharide modulates immune response in the colorectal tumor microenvironment
Sulit, A. K., Daigneault, M. C., Allen‐Vercoe, E., Silander, O., Hock, B. D., McKenzie, J., Pearson, J. F., Frizelle, F., Schmeier, S., & Purcell, R. V. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00429-w · Cited by 52
“increased colitis-associated cancer (CAC) in an inflammasome context (47,48) despite IL-18 164”
NLRP6 in infection and inflammation
Anand, P. K., & Kanneganti, T. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.06.009 · Cited by 47
“Enhanced susceptibility to colitis and colorectal tumorigenesis has also been demonstrated before in mice lacking components of the NLRP3 inflammasome owing to reduced IL-18 production in these mice [31-33].”
BackgroundNLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
Zhong, C., Wang, R., Hua, M., Zhang, C., Han, F., Xu, M., Yang, X., Li, G., Hu, X., Sun, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661939 · Cited by 56
“Though the inflammasome activation and IL-18 signaling pathways are largely beneficial in colitis-associated colorectal cancer (32, 36), it has been widely accepted that inflammasome can promote the development of many malignant tumors, including head and neck squamous cell carcinoma, fibrosarcoma, melanoma, gastric c…”
BackgroundMethodProtein Kinase R and the Inflammasome
Yim, H. C. H., & Williams, B. R. G. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0008 · Cited by 42
DNA-sensing inflammasomes: regulation of bacterial host defense and the gut microbiota
Man, S. M., Karki, R., & Kanneganti, T. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw028 · Cited by 46
“NLRP3 is required for mediating protection against chemically-induced colitis in mice (Allen et al. 2010; Zaki et al. 2010a,b; Hirota et al. 2011).”
BackgroundAsbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome
Thompson, J. K., MacPherson, M. B., Beuschel, S. L., & Shukla, A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.11.008 · Cited by 44
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD
Astorga, J., Gasaly, N., Dubois‐Camacho, K., la Fuente, M. D., Landskron, G., Faber, K. N., Urra, F. A., & Hermoso, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028953 · Cited by 47
“Whilst another study showed worse survival and clinical scores than wild-type mice (113).”
BackgroundResultInfluentialPyroptosis and inflammasomes in cancer and inflammation
Wang, J., Hua, S., Bao, H., Yuan, J., Zhao, Y., & Chen, S. (2023) · MedComm · doi:10.1002/mco2.374 · Cited by 47
Interactions between Nod-Like Receptors and Intestinal Bacteria
de Zoete, M. R., & Flavell, R. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00462 · Cited by 50
“Initially, NLRP3 was reported to have a key role in protecting intestinal homeostasis, as NLRP3-deficient mice were shown to have an altered microbiota and displayed increased susceptibility to DSS-colitis (124, 125) and tumorigenesis (126).”
BackgroundThe inflammasomes, immune guardians at defence barriers
Palazón‐Riquelme, P., & López‐Castejón, G. (2018) · Immunology · doi:10.1111/imm.12989 · Cited by 48
Lactate and TGF‐β antagonistically regulate inflammasome activation in the tumor microenvironment
Tu, C., Hu, Y., Zhou, P., Guo, X., Gu, C.-C., Zhang, Y., Li, A., & Liu, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30169 · Cited by 45
Ma, W., Wang, Z., Zhao, Y., Wang, Q., Zhang, Y., Pan, L., Lu, W., Yan, S., Zhou, J. Y., Li, X., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6614574 · Cited by 43
“Inflammatory reaction contributes to tumor development and progression [27].”
BackgroundCancer-associated pyroptosis: A new license to kill tumor
Kong, Q., & Zhang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1082165 · Cited by 48
“IL-1b is also protective in colitis-associated cancer (81) and myeloma and B-cell lymphoma (82).”
BackgroundThe multifaceted roles of inflammasome proteins in cancer
Pétrilli, V. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000346 · Cited by 47
Rodrigues, L., Donado-Pestana, C. M., Moura, M. H. C., Silva, R. R. E., Pessoa, É. V. M., & Genovese, M. I. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110139 · Cited by 44
The Evolutionary Landscape of Cytosolic Microbial Sensors in Humans
Vasseur, E., Boniotto, M., Patin, É., Laval, G., Quach, H., Manry, J., Crouau‐Roy, B., & Quintana‐Murci, L. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.008 · Cited by 47
“For example, increasing evidence suggests that NALPs are involved in the maintenance of intestinal homeostasis, as shown for the murine Nalp3, the absence of which is associated with greater tissue damage and colitis.(43,44) It is also becoming evident that many NALP genes are expressed specifically in gametes and emb…”
BackgroundComprehensive review of ASC structure and function in immune homeostasis and disease
Agrawal, I., & Jha, S. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05345-2 · Cited by 47
What role does pyroptosis play in cancer?
Huang, C. L., Li, J., & Zhang, C. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101587 · Cited by 44
Leclerc, D., Lévesque, N., Cao, Y., Deng, L.-Y., Wu, Q. H., Powell, J., Sapienza, C., & Rozen, R. R. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0198 · Cited by 41
“Mice lacking Pycard demonstrate polyp formation (40); PYCARD is an inflammasome-associatedmolecule with influences on diabetes, obesity, and cancer (41).”
BackgroundNLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions
Sharma, N., & Jha, S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2123-8 · Cited by 44
“NLRP3 expression and function in hematopoietic cells but not in intestinal epithelial or stromal cells is responsible for protection against increased tumorigenesis [38].”
BackgroundHuang, L., Duan, S., Shao, H., Zhang, A., Chen, S., Zhang, P., Wang, N., Wang, W., Wu, Y., Wang, J., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-0983-4 · Cited by 44
Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease
Özsoy, M., Stummer, N., Zimmermann, F., Feichtinger, R. G., Sperl, W., Weghuber, D., & Schneider, A.-M. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac024 · Cited by 43
Inflammasome-Microbiota Interplay in Host Physiologies
Ayres, J. S. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.10.013 · Cited by 46
CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings
Li, Q., Zhang, X., Wang, W., Li, L., Xu, Q., Wu, X., & Gu, Y. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.025 · Cited by 40
Interleukin 1β—A Potential Salivary Biomarker for Cancer Progression?
Idris, A., Ghazali, N. B., & Koh, D. S. Q. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s25375 · Cited by 50
Han, Y., Jeong, M., Park, J., Kim, M.-Y., Go, E., Cha, J.-Y., Kim, K. J., & Hahm, K. B. (2016) · Oncotarget · doi:10.18632/oncotarget.11544 · Cited by 40
“We presented lipid profiles as the ratio of ω-6 : ω-3 PUFAs, since the reported average ratios of ω-6:ω-3 PUFAs remain 10–4 : 1 in humans other than those with a Western diet and 15–20 : 1 in humans following a Western diet deficient in ω-3 PUFAs [29]; fat-1 TG mice showed a ratio of ω-6:ω-3 PUFAs significantly lower…”
Background
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.